Short Interest in Apyx Medical Corporation (NASDAQ:APYX) Drops By 27.6%

Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 299,300 shares, a decrease of 27.6% from the May 15th total of 413,600 shares. Based on an average daily volume of 184,700 shares, the short-interest ratio is currently 1.6 days. Approximately 0.9% of the shares of the company are sold short.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Nantahala Capital Management LLC boosted its holdings in Apyx Medical by 2.8% in the 1st quarter. Nantahala Capital Management LLC now owns 3,258,048 shares of the company's stock worth $4,464,000 after buying an additional 88,248 shares during the period. Archon Capital Management LLC boosted its holdings in Apyx Medical by 0.8% in the 4th quarter. Archon Capital Management LLC now owns 3,140,281 shares of the company's stock worth $4,962,000 after buying an additional 25,000 shares during the period. Royce & Associates LP boosted its holdings in Apyx Medical by 1.3% in the 4th quarter. Royce & Associates LP now owns 2,615,369 shares of the company's stock worth $4,132,000 after buying an additional 32,879 shares during the period. Silverberg Bernstein Capital Management LLC boosted its holdings in Apyx Medical by 13.2% in the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 646,569 shares of the company's stock worth $886,000 after buying an additional 75,337 shares during the period. Finally, Commonwealth Equity Services LLC boosted its holdings in shares of Apyx Medical by 3.0% during the 4th quarter. Commonwealth Equity Services LLC now owns 527,061 shares of the company's stock valued at $833,000 after purchasing an additional 15,500 shares during the last quarter. Institutional investors own 55.33% of the company's stock.

Apyx Medical Stock Performance

Shares of NASDAQ:APYX traded up $0.29 during midday trading on Friday, hitting $2.00. The company had a trading volume of 79,753 shares, compared to its average volume of 79,615. The company has a debt-to-equity ratio of 3.21, a current ratio of 5.45 and a quick ratio of 4.64. The company has a market cap of $75.58 million, a price-to-earnings ratio of -3.64 and a beta of 1.21. Apyx Medical has a 12-month low of $0.76 and a 12-month high of $2.06. The company has a fifty day moving average of $1.39 and a two-hundred day moving average of $1.39.

Apyx Medical (NASDAQ:APYX - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.03. The company had revenue of $9.43 million during the quarter, compared to the consensus estimate of $9.39 million. Apyx Medical had a negative net margin of 42.37% and a negative return on equity of 156.85%. On average, equities research analysts expect that Apyx Medical will post -0.68 EPS for the current fiscal year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.